Australia - English - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin lispro, quantity: 100 iu/ml - injection, solution - excipient ingredients: hydrochloric acid; dibasic sodium phosphate heptahydrate; glycerol; metacresol; zinc oxide; sodium hydroxide; water for injections - for the treatment of patients with type i (iddm) and type ii (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Ireland - English - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - insulin human - solution for injection - 100 iu/ml - insulins and analogues for injection, fast-acting

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - insulin (human) (isophane) - injection - 100 iu/ml - insulin (human) (isophane) 100 iu/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

eli lilly and company - insulin human (recombinant dna) - suspension for injection - 100iu/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

eli lilly and company - insulin nph, regular - suspension for injection - 70, 30 iu/ml

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - humulin n - suspension for injection (sc) - 100 iu/ml

Kenya - English - Pharmacy and Poisons Board

eli lilly and company 16ch.des conquelicots p.o box 580 ch-1214 - human insulin - suspension for injection - humulin injections contain biosynthetic human… - insulins and analogues for injection

Malta - English - Medicines Authority

eli lilly & co. limited - insulin recombinant, human - suspension for injection - insulin recombinant, human 100 iu/ml - drugs used in diabetes

Australia - English - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin lispro, quantity: 100 iu/ml - injection, solution - excipient ingredients: glycerol; sodium hydroxide; water for injections; hydrochloric acid; zinc oxide; dibasic sodium phosphate heptahydrate; metacresol - for the treatment of patients with type i (iddm) and type ii (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Ireland - English - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - insulin human - solution for injection - 100 iu/ml - insulins and analogues for injection, fast-acting